GRI Bio (GRI) EPS (Basic) (QoQ) (2020 - 2026)
GRI Bio (GRI) EPS (Basic) (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | GRI Bio | 2.99 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.30% |
| Dec 31, 2025 | -521.35% |
| Sep 30, 2025 | -0.78% |
| Jun 30, 2025 | 77.37% |
| Mar 31, 2025 | 94.29% |
| Dec 31, 2024 | -787.59% |
| Sep 30, 2024 | 86.34% |
| Jun 30, 2024 | 17.33% |
| Mar 31, 2024 | 98.71% |
| Dec 31, 2023 | -759.35% |
| Sep 30, 2023 | 75.77% |
| Jun 30, 2023 | -7.25% |
| Mar 31, 2023 | 84.69% |
| Dec 31, 2022 | -3,006.08% |
| Sep 30, 2022 | 23.05% |
| Jun 30, 2022 | 94.89% |
| Mar 31, 2022 | 73.83% |
| Dec 31, 2021 | -704.54% |
| Sep 30, 2021 | 45.63% |
| Jun 30, 2021 | 39.65% |